Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4354 followers
Created: 2025-07-21 17:45:07 UTC

$ Direct Financial Obligation:

ACURA PHARMACEUTICALS, INC. reported receiving loans totaling $XXXXXXX on July X and July 18, 2025, which contribute to a principal balance of $8,394,279, indicating potential financial difficulties and a risk of scaling back operations if additional financing is not secured by early-August 2025.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947352149413007727/c:line.svg)

**Related Topics**
[acura](/topic/acura)

[Post Link](https://x.com/USCorpFilings/status/1947352149413007727)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

USCorpFilings Avatar SEC Filings Digest @USCorpFilings on x 4354 followers Created: 2025-07-21 17:45:07 UTC

$ Direct Financial Obligation:

ACURA PHARMACEUTICALS, INC. reported receiving loans totaling $XXXXXXX on July X and July 18, 2025, which contribute to a principal balance of $8,394,279, indicating potential financial difficulties and a risk of scaling back operations if additional financing is not secured by early-August 2025.

XXX engagements

Engagements Line Chart

Related Topics acura

Post Link

post/tweet::1947352149413007727
/post/tweet::1947352149413007727